SurvivorNetSurvivorNet Facebook ad: “New Advances in Relapsed Myeloma Treatment”
Ran for 94 days, from February 23 to May 28, 2026, the last day Crush saw it.
Run by SurvivorNet on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 1842762083056828
- Platforms
- Relaunches
- 0
Ad text
CAR-T. Bispecific antibodies. Novel combinations. Relapsed multiple myeloma treatment has changed dramatically in recent years. Are you aware of all the options available after relapse?SurvivorNet gives you direct access to expert insight so you can understand the newest therapies and what they might mean for you.Stay informed. Stay empowered.
Where the ad sends people
survivornet.com
New Advances in Relapsed Myeloma Treatment
Related: New Hope for Multiple Myeloma Patients: Study of New CAR T-cell Therapy Shows The Best Result In The History of The Disease
Learn more: survivornet.com(opens in a new tab)
